HIF1α-mediated RHOA upregulation has been suggested across multiple types of cancers, including hepatocellular, lung, breast and colorectal cancer (Du et al., 2024; Kataoka et al., 2019; Semenza, 2016; Zhang et al., 2020b). Here, HIF1A is linked to cancer.